NCT07142876

Brief Summary

Evaluation Of Liver Resection Using Harmonic Scalpel Versus Cavitron Ultrasonic Surgical Aspirator (CUSA) Introduction The mode of parenchymal transection in hepatic resection has been a topic of great debate for decades. Many resections have now evolved into laparoscopic , and robotic-assisted procedures to limit morbidity. Morbidity and mortality after hepatic resection has progressively improved over the years due to improved equipment, operative technique \[3\], and anesthetic management. Prior to 1980, mortality rates were reported to be in the 10-20% range with many deaths related to perioperative hemorrhage. Now perioperative mortality has dropped significantly to approximately 5%. The clamp-crush technique, first reported in 1974, has been used for decades and remains the standard means of parenchymal division for many surgeons. Control of intraoperative hemorrhage has been one of the principle technical problems in advancing liver surgery. Excess blood loss and intraoperative blood transfusions have been shown to be associated with increased perioperative mortality and morbidity including an increased rate of hepatocellular carcinoma recurrence . Transfusions are also associated with increased infections and with increased cost. Costs of blood transfusions were recently examined in surgical patients. Many devices are now available to surgeons for division of the liver parenchyma in both open and minimally invasive surgery including: the CUSA (Tyco Healthcare, Mansfield, MA), Harmonic Scalpel (Ethicon Endo-Surgery, Cincinnati, OH, USA), Ligasure (Valley Lab, Tyco Healthcare, Boulder, CO, USA), Tissue Link (Salient Surgical Technologies, Portsmouth, NH), water-jet dissection, radiofrequency, microwave assisted resection, vascular staplers, and others In this study, we looked at the TissueLink bipolar sealer device that was used in combination with the CUSA in group 1 termed the CUSA/TissueLink group, and the Harmonic Scalpel in the group 2 termed Harmonic Scalpel/TissueLink. The TissueLink uses radiofrequency energy focused near the end of the device for electrocautery and a low volume saline drip that produces ohmic heat causing precoagulation of hepatic parenchyma. The saline keeps the temperature at or below 100 C to avoid eshcar formation ultimately helping prevent delayed biliary leak and hemorrhage. The hemostatic effects of TissueLink are a result of its disruption of the collagen in blood vessels causing closing of the lumen . The CUSA, a commonly used device in hepatic resection, was used in combination with the TissueLink in this study. We previously described this combination of devices reporting a shorter length of hospital stay, decreased operative time, and decreased intraoperative blood transfusion . CUSA uses ultrasonic energy to fragment and aspirate parenchymal tissue. This exposes biliary as well as vascular structures that may then be closed in a variety of ways at the surgeon's discretion. It allows for a precise transection plane allowing preservation of normal hepatic tissue . The Harmonic Scalpel, used in this study in combination with the TissueLink, utilizes ultrasonic vibration of two blades causing destruction of hydrogen bonds. This disruption of hydrogen bonds causes protein denaturization coagulating small vessels of 3 mm diameter. The parenchyma is also cut when the blades move in a saw-like fashion In this study, we evaluated the safety and efficacy of two different techniques described above for the division of the hepatic parenchyma in order to improve perioperative outcomes.

Trial Health

65
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
50

participants targeted

Target at P25-P50 for not_applicable

Timeline
8mo left

Started Aug 2025

Status
not yet recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress52%
Aug 2025Dec 2026

First Submitted

Initial submission to the registry

August 19, 2025

Completed
3 days until next milestone

Study Start

First participant enrolled

August 22, 2025

Completed
5 days until next milestone

First Posted

Study publicly available on registry

August 27, 2025

Completed
1.2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 1, 2026

Expected
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

December 30, 2026

Last Updated

August 27, 2025

Status Verified

August 1, 2025

Enrollment Period

1.2 years

First QC Date

August 19, 2025

Last Update Submit

August 26, 2025

Conditions

Keywords

liver resectionCUSACavitron Ultrasonic Surgical AspiratorHarmonic

Outcome Measures

Primary Outcomes (3)

  • Postoperative bile leakage

    Postoperative bile leakage was diagnosed once bile was detected from the wound or the drain or drained intra-abdominal collection with total bilirubin level in the fluid more than 3 times that in the serum.

    Day 14

  • The liver resection time

    The liver resection time was defined as the duration from the beginning of parenchymal transection until the completion of transection with complete achievement of haemostasis from the liver cut surface.

    Day 1

  • Blood loss

    Blood loss during parenchymal transection and immediately after hepatectomy until completion of the procedures was included and estimated by the volume of blood suctioned and subtraction of rinse fluids and/or weighting the swabs that were used during transection, (Every 1 mL of blood is equivalent to 1 g increase in the swab weight).

    Day 1

Secondary Outcomes (1)

  • liver functions

    Day 14

Study Arms (2)

Liver resection with Cavitron Ultrasonic Surgical Settings Aspirator (CUSA)

ACTIVE COMPARATOR

In-group A Cavitron Ultrasonic Surgical Settings Aspirator (CUSA) with standard tip was used for parenchymal transection with the following Settings; 23 kHz, 70 Watt, and continuous irrigation at rate of 4-6 ml/min with normal saline and the vessel coagulation was performed by the bipolar sealer (Valleylab force FX electrosurgical generator, Medtronic, Minneapolis, USA), the power was used at 50 Watt coagulation.

Procedure: Liver resection Cavitron Ultrasonic Surgical Aspirator (CUSA)

Liver resection with the harmonic scalpel

ACTIVE COMPARATOR

In group B the harmonic scalpel (Ethicon EndoSurgery, Johnson \& Johnson, New Jersey, USA) was set at a high power, and blood vessels or bile ducts up to 3-4 mm in diameter were coagulated for 5-6 seconds.

Procedure: Liver resection with the harmonic scalpel

Interventions

In-group A Cavitron Ultrasonic Surgical Settings Aspirator (CUSA) with standard tip was used for parenchymal transection with the following Settings; 23 kHz, 70 Watt, and continuous irrigation at rate of 4-6 ml/min with normal saline and the vessel coagulation was performed by the bipolar sealer (Valleylab force FX electrosurgical generator, Medtronic, Minneapolis, USA), the power was used at 50 Watt coagulation.

Also known as: Group A
Liver resection with Cavitron Ultrasonic Surgical Settings Aspirator (CUSA)

In group B the harmonic scalpel (Ethicon EndoSurgery, Johnson \& Johnson, New Jersey, USA) was set at a high power, and blood vessels or bile ducts up to 3-4 mm in diameter were coagulated for 5-6 seconds.

Also known as: Group B
Liver resection with the harmonic scalpel

Eligibility Criteria

Age6 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • patients needing liver resection in normal liver and cirrhotic liver child-pough A and early B
  • Age \> 6 and \< 70 years old
  • One or two small (5 cm or less) hepatic lesions confined to the liver with no extra hepatic involvement
  • Patients with -ve markers for viral hepatitis

You may not qualify if:

  • patients with age \< 6 or \> 70 years old
  • liver cirrhosis Child-pough C
  • liver cell failure
  • very large lesions including most of the liver tissue
  • hepatic lesions with vascular invasion
  • evidence of metastasis in cases with HCC
  • patients with +ve markers for viral hepatitis

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Carcinoma, HepatocellularAbdominal Injuries

Interventions

Hepatectomy

Condition Hierarchy (Ancestors)

AdenocarcinomaCarcinomaNeoplasms, Glandular and EpithelialNeoplasms by Histologic TypeNeoplasmsLiver NeoplasmsDigestive System NeoplasmsNeoplasms by SiteDigestive System DiseasesLiver DiseasesWounds and Injuries

Intervention Hierarchy (Ancestors)

Digestive System Surgical ProceduresSurgical Procedures, Operative

Study Officials

  • AbdElaal A Prof. AbdElaal Ali Sleem, professor

    AbdElaal Ali Sleem

    STUDY CHAIR

Central Study Contacts

Mohamed Mahmoud Mohamed Hassanein, Assistant lecturer

CONTACT

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
TREATMENT
Intervention Model
FACTORIAL
Model Details: prospective randomized comparative clinical trial study analyzing outcomes of liver resection by two different techniques CUSA or Harmonic scalpel .This will be a prospective comparative study at Sohag University Hospital and Assuit University Hospital, Egypt The study population was divided into two equal groups (25 per group) according to the method of liver transection: group A by CUSA and group B by harmonic scalpel (HS). Inclusion criteria patients needing liver resection in normal liver and cirrhotic liver child-pough A and early B with: Age \> 6 and \< 70 years old, One or two small (5 cm or less) hepatic lesions confined to the liver with no extra hepatic involvement, Patients with -ve markers for viral hepatitis. The exclusion criteria: patients with age \< 6 or \> 70 years old, liver cirrhosis Child-pough C, liver cell failure, very large lesions including most of the liver tissue, vascular invasion, evidence of metastasis in cases with HCC, positive hepatitis
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant lecturer

Study Record Dates

First Submitted

August 19, 2025

First Posted

August 27, 2025

Study Start

August 22, 2025

Primary Completion (Estimated)

November 1, 2026

Study Completion (Estimated)

December 30, 2026

Last Updated

August 27, 2025

Record last verified: 2025-08

Data Sharing

IPD Sharing
Will not share

protecting my patients privacy and confidentiality